Saudi Arabia Financial Aid To Pakistan: Pakistan gets $3 billion from Saudi Arabia as ‘support’ to shore up forex reserves as UAE debt looms

Pakistan gets $3bn from Saudi Arabia as ‘support’ to shore up forex reserves as UAE debt looms Saudi Arabia has provided new financial help to Pakistan with an extra $3 billion deposit. It has also extended an existing $5 billion loan. This support is important for Pakistan as it struggles to meet its growing debt…

Read More

Stock market today (April 15, 2026): Nifty50 opens above 24,200; BSE Sensex rallies over 1,200 points as oil prices drop on US-Iran peace talks optimism

Stock market today (AI image) Stock market today: Sensex and Nifty50 rallied strongly in opening trade on Wednesday after optimism surrounding renewed US-Iran peace talks led oil prices to drop. While Nifty50 went above 24,200, BSE Sensex rose over 1,200 points. At 9:17 AM, Nifty50 was at around 24,223.45, up 381 points or 1.60%. BSE…

Read More

Asian stocks today: Markets rally as hopes of US-Iran talks lift sentiment, oil prices ease

File photo (Picture credit: AP) Asian markets rose on Wednesday, following strong gains on Wall Street. Lower oil prices and renewed hopes for talks between the United States and Iran increased investor confidence.MSCI’s broadest index of Asia-Pacific shares outside Japan rose 1.5% to a six-week high, while Japan’s Nikkei gained 1.2%, inching closer to its…

Read More

Infosys rolls out ‘silicon to application’ AI strategy

Bengaluru: Infosys has set its new AI strategy, “silicon to application,” in motion. The playbook aims to span the full AI ecosystem-from hardware to end-user applications-through targeted investments and partnerships across each layer.At the silicon layer, Infosys has partnered with Nvidia and Intel. “These partnerships matter most when clients need AI to run on their…

Read More

`Indian pharma must balance generics with innovation’

NEW DELHI: India’s pharmaceutical industry must focus on both generics and innovative products, as well as develop products specially tailored for the country’s patient needs. Domestic companies particularly smaller to mid-sized players can carve out a strong role in rare diseases and niche patient segments, where agility and specialised research can drive meaningful breakthroughs, pharma…

Read More